IMMD

ImmuDyne, Inc.

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 3/08/2017
Contact Info
  • 50 Spring Meadow Rd
  • Mount Kisco, NY 10549

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Mar 31, 2017 10-Q
CIK 0000948320
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2833 - Medicinal and botanicals
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts
Mark McLaughlin President, CEO
John Strawn Securities Counsel
Sven Rohmann CMO
Joseph DiTrolio CMO
Ryan Aldridge Outside Director
Company Directors
Anthony Bruzzese, M.D. Chairman, Independent Director, Audit Committee Member
Joseph DiTrolio
Sven Rohmann
John Strawn Independent Director, Audit Committee Member
Service Providers
Accounting/Auditing Firm
PKF O'Connor Davies, LLP
29 Broadway
New York, NY, 10006
United States
 
Securities Counsel
Kane Kessler, P.C.
1350 Avenue of the Americas
New York, NY, 10019
United States
 
Mitul Patel, Esq.
 
Investor Relations Firm

Not Available
Company History
  • Formerly=Anina Resources, Inc to 11-87
IMMD Security Details
Share Structure
Market Value1 $18,508,141 a/o Jul 21, 2017
Authorized Shares 50,000,000 a/o Sep 30, 2016
Outstanding Shares 40,543,573 a/o Jul 10, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 11,490,119 a/o Aug 15, 2016
Par Value 0.01
Shareholders
Shareholders of Record 324 a/o May 24, 2017
Short Selling Data
Short Interest 156,096 (0%)
Jun 30, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security